Sinopep Biopharma

China GMP peptide CDMO. 20-30 metric tons annual capacity. FDA-inspected facilities. Large-scale oligonucleotide manufacturing. Ships commercial APIs internationally.

Directory assessment: Sinopep Biopharma is listed as a CDMO in the peptide supply chain, serving Asia markets from China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.